This resource pack will support pharmacists, who play a crucial role in medicines optimisation, to have critical conversations about the prescription of antipsychotics in dementia and reduce inappropriate prescribing. Read more »
Presentations on projects underway to reduce the inappropriate prescribing of antipsychotics in care homes. Read more »
The percentage of patients in the South West of England being prescribed antipsychotic drugs has fallen sharply in the past six years, with health care leads saying that is a clear indication that standards of care are improving. Read more »
The recently published audit of antipsychotic prescribing for dementia shows a 52% decrease in the rate of prescribing between 2008 and 2011. Read more »
This guide summarises some of the main considerations in the prescribing of antipsychotic drugs to people with dementia. Read more »
Join the Right Prescription on-line community and take action to reduce the inappropriate prescribing of antipsychotic drugs for people with dementia. Read more »
Studies into depression and agitation and aggression will play a key role in helping to reduce inappropriate prescriptions of antipsychotics for people with dementia. Read more »
The June 2011 edition of the Brain Waves newsletter, produced by Innovations in Dementia, includes features on: The power of video; Technology; Call to action on antipyschotic drugs; Age UK Devon. Read more »
The NHS Institute for Innovation and Improvement and the Dementia Action Alliance have launched a call to action to work together to improve the quality of life of people with dementia and their carers by reducing the inappropriate use of antipsychotics for these people. Read more »
A new clinic to help find a treatment for Alzheimer’s disease will be set up in Bristol after a £1 million grant was made to researchers. Read more »
This dataset from the NHS Information Centre provides information about Primary Care Trust (PCT) prescribing data between January and March 2011. Read more »
This compendium is a local enabler for change and seeks to improve outcomes for people with dementia and their carers. Read more »
The innovative approach means that new, better treatments could be available in just seven years, bringing hope to people with dementia and their carers. Read more »
Lithium treatment may slow the development of dementia, according to a study published in the British Journal of Psychiatry (Wednesday 27 April 2011). Read more »
The final NICE guidance means the drugs Aricept, Exelon and Reminyl will be available on prescription to people in the early and moderate stages of Alzheimer’s and Ebixa will be available to people in the late stages. Read more »